Arvinas Inc (NASDAQ: ARVN) open the trading on Wednesday, with great promise as it jumped 4.90% to $12.41, before settling in for the price of $11.83 at the close. Taking a more long-term approach, ARVN posted a 52-week range of $5.90-$20.63.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -5.32%. Meanwhile, its Annual Earning per share during the time was -5.32%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 74.44%. This publicly-traded company’s shares outstanding now amounts to $70.80 million, simultaneously with a float of $54.01 million. The organization now has a market capitalization sitting at $797.02 million. At the time of writing, stock’s 50-day Moving Average stood at $11.50, while the 200-day Moving Average is $8.67.
Arvinas Inc (ARVN) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Biotechnology industry. Arvinas Inc’s current insider ownership accounts for 15.91%, in contrast to 89.06% institutional ownership. According to the most recent insider trade that took place on Nov 07 ’25, this organization’s Chief Accounting Officer sold 230 shares at the rate of 9.89, making the entire transaction reach 2,275 in total value, affecting insider ownership by 31,697. Preceding that transaction, on Sep 22 ’25, Company’s Director bought 30,000 for 7.57, making the whole transaction’s value amount to 227,010. This particular insider is now the holder of 76,021 in total.
Arvinas Inc (ARVN) Earnings and Revenue Records
Arvinas Inc’s EPS increase for this current 12-month fiscal period is 74.44% and is forecasted to reach -3.00 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -3.53% through the next 5 years, which can be compared against the -5.32% growth it accomplished over the previous five years trading on the market.
Arvinas Inc (NASDAQ: ARVN) Trading Performance Indicators
Let’s observe the current performance indicators for Arvinas Inc (ARVN). It’s Quick Ratio in the last reported quarter now stands at 5.70. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.55.
In the same vein, ARVN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.80, a figure that is expected to reach -0.51 in the next quarter, and analysts are predicting that it will be -3.00 at the market close of one year from today.
Technical Analysis of Arvinas Inc (ARVN)
[Arvinas Inc, ARVN] recent stats showed that its last 5-days Average volume was poorer than the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 46.52% While, its Average True Range was 58.78.
Raw Stochastic average of Arvinas Inc (ARVN) in the period of the previous 100 days is set at 75.09%, which indicates a major fall in contrast to 80.98% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.53 that was higher than 0.53 volatility it exhibited in the past 100-days period.
